Paul R. Hansen - 19 Aug 2021 Form 4 Insider Report for Vyant Bio, Inc.

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
19 Aug 2021
Net transactions value
+$47,000
Form type
4
Filing time
23 Aug 2021, 15:42:45 UTC
Previous filing
13 Jul 2021
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $47,000 +20,000 +3.3% $2.35 617,957 19 Aug 2021 Direct
holding VYNT Common Stock, $0.0001 par value 64,901 19 Aug 2021 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.